Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2017

01-03-2017 | Original Article – Cancer Research

HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer

Authors: Wen-Jin Ding, Min Zhou, Mei-Mei Chen, Chun-Ying Qu

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2017

Login to get access

Abstract

Purpose

The homeobox B8 (HOXB8) functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with a wide variety of tumor; however, its function in gastric cancer has not been clarified. In the present study, the expression of HOXB8 in gastric cancer tissues and influence of HOXB8 on gastric cancer cellular were evaluated.

Methods

The expression levels of HOXB8 mRNA in human gastric cancer tissues were analyzed through quantitative RT-PCR. To test the role of HOXB8 in gastric cancer metastasis, the cell transwell assay was performed. Microarray, ChIP-qPCR, and Western blot were used to explore the possible mechanism that HOXB8 promotes gastric cancer cells metastasis.

Results

In this study, we found that HOXB8 showed higher expression in metastatic tissues than no-metastatic tissues. Overexpression of HOXB8 can promote gastric cancer cells migration and invasion, while silencing HOXB8 leads to the opposite results. Overexpression of HOXB8 also increases the rate of metastasis in NCI-N87 mice, while silencing HOXB8 has the opposite results. Furthermore, HOXB8 promotes epithelial–mesenchymal transformation of AGS cells. We also found that ZEB2 can interact with HOXB8 and may be a downstream factor of HOXB8 by using microarray. Knockdown of ZEB2 can inhibit HOXB8-induced migration and invasion capacity, as well as the epithelial–mesenchymal transformation in gastric cancer cells.

Conclusions

The results showed that HOXB8 plays an important role in the development and metastasis of gastric carcinoma.
Literature
go back to reference Bhattacharjee A, Ghangal R, Garg R, Jain M (2015) Genome-wide analysis of homeobox gene family in legumes: identification, gene duplication and expression profiling. PLoS ONE 10:e0119198CrossRefPubMedPubMedCentral Bhattacharjee A, Ghangal R, Garg R, Jain M (2015) Genome-wide analysis of homeobox gene family in legumes: identification, gene duplication and expression profiling. PLoS ONE 10:e0119198CrossRefPubMedPubMedCentral
go back to reference Chen SK, Kurdyukov S, Kereszt A, Wang XD, Gresshoff PM, Rose RJ (2009) The association of homeobox gene expression with stem cell formation and morphogenesis in cultured Medicago truncatula. Planta 230:827–840CrossRefPubMedPubMedCentral Chen SK, Kurdyukov S, Kereszt A, Wang XD, Gresshoff PM, Rose RJ (2009) The association of homeobox gene expression with stem cell formation and morphogenesis in cultured Medicago truncatula. Planta 230:827–840CrossRefPubMedPubMedCentral
go back to reference Chen WM et al. (2016a) Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients. J Cancer Res Clin Oncol 142(11):2375–2382CrossRefPubMed Chen WM et al. (2016a) Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients. J Cancer Res Clin Oncol 142(11):2375–2382CrossRefPubMed
go back to reference Chen Y et al (2016) SOX2 inhibits metastasis in gastric cancer. J Cancer Res Clin Oncol 142:1221–1230CrossRefPubMed Chen Y et al (2016) SOX2 inhibits metastasis in gastric cancer. J Cancer Res Clin Oncol 142:1221–1230CrossRefPubMed
go back to reference Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG, Hirokawa K, Nakamura T (2001) Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 29:856–863CrossRefPubMed Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG, Hirokawa K, Nakamura T (2001) Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 29:856–863CrossRefPubMed
go back to reference Hsu SH et al (2013) Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. Cancer Res 73:508–518CrossRefPubMed Hsu SH et al (2013) Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma. Cancer Res 73:508–518CrossRefPubMed
go back to reference Liu H, Zhang X, Li J, Sun B, Qian H, Yin Z (2015a) The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells. J Cancer Res Clin Oncol 141:189–201CrossRefPubMed Liu H, Zhang X, Li J, Sun B, Qian H, Yin Z (2015a) The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells. J Cancer Res Clin Oncol 141:189–201CrossRefPubMed
go back to reference Liu YJ, Zhu Y, Yuan HX, Zhang JP, Guo JM, Lin ZM (2015b) Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis. Tumour Biol 36:2821–2829CrossRefPubMed Liu YJ, Zhu Y, Yuan HX, Zhang JP, Guo JM, Lin ZM (2015b) Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis. Tumour Biol 36:2821–2829CrossRefPubMed
go back to reference Nantajit D, Lin D, Li JJ (2015) The network of epithelial–mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 141:1697–1713CrossRefPubMed Nantajit D, Lin D, Li JJ (2015) The network of epithelial–mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 141:1697–1713CrossRefPubMed
go back to reference Stavnes HT et al (2013) HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Gynecol Oncol 129:358–363CrossRefPubMed Stavnes HT et al (2013) HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Gynecol Oncol 129:358–363CrossRefPubMed
go back to reference Techasen A, Namwat N, Loilome W, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P (2014) Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. J Hepato-biliary Pancreat Sci 21:703–711CrossRef Techasen A, Namwat N, Loilome W, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P (2014) Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. J Hepato-biliary Pancreat Sci 21:703–711CrossRef
go back to reference Wang Y et al (2014) CUL4A induces epithelial–mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res 74:520–531CrossRefPubMed Wang Y et al (2014) CUL4A induces epithelial–mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res 74:520–531CrossRefPubMed
go back to reference Yang YC et al (2009) A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur J Gastroenterol Hepatol 21:1016–1023CrossRefPubMed Yang YC et al (2009) A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur J Gastroenterol Hepatol 21:1016–1023CrossRefPubMed
go back to reference Zhang H et al (2013) KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 139:1033–1042CrossRefPubMed Zhang H et al (2013) KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 139:1033–1042CrossRefPubMed
Metadata
Title
HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer
Authors
Wen-Jin Ding
Min Zhou
Mei-Mei Chen
Chun-Ying Qu
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2017
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2283-4

Other articles of this Issue 3/2017

Journal of Cancer Research and Clinical Oncology 3/2017 Go to the issue